Amarin Corp Plcuk (AMRN) Cash & Equivalents (QoQ) (2010 - 2026)

Amarin Corp Plcuk (AMRN) Cash & Equivalents (QoQ) (2010 - 2026) Analysis & Trends

Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Gsk 92,316,836.42 Bn 92,316,831.46 Bn 7.76 Bn
2 Eli Lilly 983.57 Bn 978.29 Bn 16.22 Bn
3 Johnson & Johnson 553.56 Bn 531.50 Bn 15.96 Bn
4 AbbVie 383.35 Bn 374.00 Bn 10.78 Bn
5 Merck 281.71 Bn 276.06 Bn 12.09 Bn
6 Amgen 182.20 Bn 170.16 Bn 5.87 Bn
7 Gilead Sciences 153.71 Bn 145.98 Bn 5.52 Bn
8 Pfizer 143.75 Bn 130.98 Bn -1.21 Bn
9 Bristol Myers Squibb 109.71 Bn 99.25 Bn 8.07 Bn
10 Amarin Corp Plcuk 6.77 Bn 6.59 Bn 17.77 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -99.85%
Dec 31, 2025 44,637.54%
Sep 30, 2025 -99.80%
Jun 30, 2025 49,200.00%
Mar 31, 2025 0.00%
Dec 31, 2024 -99.81%
Sep 30, 2024 -27.33%
Jun 30, 2024 41,023.81%
Mar 31, 2024 0.00%
Dec 31, 2023 0.19%
Sep 30, 2023 0.00%
Jun 30, 2023 -99.73%
Mar 31, 2023 36,498.85%
Dec 31, 2022 -86.66%
Sep 30, 2022 -98.28%
Jun 30, 2022 4.02%
Mar 31, 2022 -0.12%
Dec 31, 2021 -1.55%
Sep 30, 2021 5,590.58%
Jun 30, 2021 -98.65%